Get startedLog in
    Picture of Regeneron Pharmaceuticals logo

    REGN — Regeneron Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    All News

    Brief: Otarmeni Receives EMA Filing Acceptance For Genetic Hearing Loss

    Picture of Regeneron Pharmaceuticals logoRegeneron Pharmaceuticals
    22/05/2026 12:01
    May 22 (Reuters) - Regeneron Pharmaceuticals Inc REGN.O:

OTARMENI™ (LUNSOTOGENE PARVEC) RECEIVES EMA FILING ACCEPTANCE FOR GENETIC HEARING LOSS

OTARMENI™ (LUNSOTOGENE PARVEC) RECEIVES EMA FILING ACCEPTANCE FOR GENETIC HEARING LOSS

Source text: ID:nGNX90Sx98

Further company coverage: REGN.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Regeneron Pharmaceuticals

    See all news